[go: up one dir, main page]

MX9603110A - Forma cristalina biodisponible de cefuroxima axetil. - Google Patents

Forma cristalina biodisponible de cefuroxima axetil.

Info

Publication number
MX9603110A
MX9603110A MX9603110A MX9603110A MX9603110A MX 9603110 A MX9603110 A MX 9603110A MX 9603110 A MX9603110 A MX 9603110A MX 9603110 A MX9603110 A MX 9603110A MX 9603110 A MX9603110 A MX 9603110A
Authority
MX
Mexico
Prior art keywords
bio
crystalline form
available crystalline
crystalline
axetil cefuroxime
Prior art date
Application number
MX9603110A
Other languages
English (en)
Other versions
MXPA96003110A (es
Inventor
Maurizio Zenoni
Mario Leone
Angelo Cattaneo
Leonardo Marsili
Original Assignee
Acs Dobfar Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acs Dobfar Spa filed Critical Acs Dobfar Spa
Publication of MXPA96003110A publication Critical patent/MXPA96003110A/es
Publication of MX9603110A publication Critical patent/MX9603110A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

La presente invencion se refiere a una forma cristalina biodisponible de cefuroxima axetil, obtenida mediante el tratamiento de cefuroxima axetil cristalina o amorfa conocida, con agua o con un disolvente orgánico miscible con agua, o con una mezcla de los mismos, a una temperatura entre +20 y +100 degree C, seguido por enfriamiento y separacion del producto cristalino por los métodos conocidos.
MX9603110A 1995-08-03 1996-07-31 Forma cristalina biodisponible de cefuroxima axetil. MX9603110A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT95MI001716A IT1277426B1 (it) 1995-08-03 1995-08-03 Forma cristallina biodisponibile del cefuroxima axetil
MIMI95A001716 1995-08-03

Publications (2)

Publication Number Publication Date
MXPA96003110A MXPA96003110A (es) 1997-06-01
MX9603110A true MX9603110A (es) 1997-06-28

Family

ID=11372130

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9603110A MX9603110A (es) 1995-08-03 1996-07-31 Forma cristalina biodisponible de cefuroxima axetil.

Country Status (24)

Country Link
US (1) US5677443A (es)
EP (1) EP0757991B1 (es)
JP (1) JPH09104685A (es)
KR (1) KR970010776A (es)
CN (1) CN1055693C (es)
AR (1) AR003973A1 (es)
AT (1) ATE195126T1 (es)
BR (1) BR9603270A (es)
CA (1) CA2179359A1 (es)
DE (1) DE69609576T2 (es)
DK (1) DK0757991T3 (es)
ES (1) ES2150052T3 (es)
FI (1) FI962937A7 (es)
GR (1) GR3034663T3 (es)
IL (1) IL118822A (es)
IT (1) IT1277426B1 (es)
MX (1) MX9603110A (es)
PT (1) PT757991E (es)
RU (1) RU2155767C2 (es)
SI (1) SI0757991T1 (es)
TR (1) TR199600691A2 (es)
TW (1) TW413635B (es)
UA (1) UA46727C2 (es)
ZA (1) ZA965234B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2725382B1 (fr) * 1994-10-05 1997-01-03 Commissariat Energie Atomique Polyazacycloalcanes, complexes tri-, tetra- ou pentaazamacrocycliques, procede de fabrication de ces polyazacycloalcanes substitues ou non et greffes sur un support et utilisations des polyazacycloalcanes
NZ299077A (en) * 1996-07-26 1998-06-26 Apotex Inc Preparation of amorphous cefuroxime axetil (a cephalosporin derivative) by dissolving crystalline cefuroxim axetil in a highly polar solvent, typically dmso and/or dmf
KR100401284B1 (ko) * 1997-06-03 2004-01-31 주식회사유한양행 1-브로모에틸 아세테이트의 제조방법
CA2209868C (en) * 1997-08-15 2001-08-14 Bernard Charles Sherman Pharmaceutical compositions comprising cefuroxime axetil
IN186539B (es) * 1997-09-29 2001-09-29 Ranbaxy Lab Ltd
ES2171056T3 (es) * 1998-02-20 2002-08-16 Fako Ilaclari A S Procedimiento para la fabricacion de cefuroxima axetil cristalina soluble.
US6384213B1 (en) 1998-10-23 2002-05-07 Ranbaxy Laboratories Limited Process for preparing a pure, pharmacopoeial grade amorphous form of cefuroxime axetil
IN190849B (es) * 2000-07-17 2003-08-23 Ranbaxy Lab Ltd
ITMI20011763A1 (it) * 2001-08-10 2003-02-10 Antibioticos Spa Processo di preparazione di cefuroxime axelite ad elevata purezza
ITMI20011925A1 (it) * 2001-09-14 2003-03-14 Antibioticos Spa Metodo applicabile su scala industriale per la preparazione di cefuroxime axetile cristallino
ES2201932B2 (es) * 2001-11-23 2005-03-16 Glaxo Group Limited Composicion farmaceutica.
CN1909889B (zh) * 2004-01-09 2010-06-02 韩美药品株式会社 头孢呋辛酯颗粒及其制备方法
CN100448879C (zh) * 2004-07-22 2009-01-07 北京化工大学 一种无定型头孢呋辛酯的制备方法
DE102005019458A1 (de) * 2005-04-25 2006-10-26 Grünenthal GmbH Darreichungsform mit verbesserter Freisetzung von Cefuroximaxetil
WO2007063552A1 (en) * 2005-12-02 2007-06-07 Lupin Limited Stable taste masked formulations of cephalosporins
DE102006019619A1 (de) * 2006-04-25 2007-10-31 Grünenthal GmbH Kristalline Modifikation von Cefuroximaxetil
CN102417451B (zh) * 2011-12-20 2013-12-04 浙江国邦药业有限公司 一种合成（r，s）1-溴代乙基乙酸酯的制备方法
WO2014040239A1 (zh) * 2012-09-12 2014-03-20 海南卫康制药(潜山)有限公司 头孢呋辛钠晶型化合物及其组合物粉针
CN106554361B (zh) * 2016-09-30 2018-10-09 华北制药河北华民药业有限责任公司 一种头孢呋辛酯口服制剂的制备方法
CN115594583A (zh) * 2022-10-13 2023-01-13 浙江东盈药业有限公司（Cn） 一种1-溴乙基乙酸酯的合成方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1094545A (en) * 1976-02-16 1981-01-27 Michael Gregson Cephalosporin antibiotics
GB1571683A (en) * 1976-02-16 1980-07-16 Glaxo Operations Ltd Ester derivatives of cefuroxime
YU44680B (en) * 1982-07-30 1990-12-31 Glaxo Lab Ltd Process for obtaining very pure amorphous form of cephuroxim axetile
GB8320521D0 (en) * 1983-07-29 1983-09-01 Glaxo Group Ltd Chemical process
US5063224A (en) * 1990-07-09 1991-11-05 Eli Lilly And Company R-cefuroxime axetil

Also Published As

Publication number Publication date
TR199600691A3 (tr) 1998-03-21
ES2150052T3 (es) 2000-11-16
EP0757991B1 (en) 2000-08-02
FI962937L (fi) 1997-02-04
CA2179359A1 (en) 1997-02-04
AU6083396A (en) 1997-02-06
IL118822A (en) 1999-11-30
IT1277426B1 (it) 1997-11-10
AR003973A1 (es) 1998-09-30
US5677443A (en) 1997-10-14
PT757991E (pt) 2000-11-30
ATE195126T1 (de) 2000-08-15
DK0757991T3 (da) 2000-09-04
DE69609576T2 (de) 2001-01-04
EP0757991A1 (en) 1997-02-12
IL118822A0 (en) 1996-10-31
JPH09104685A (ja) 1997-04-22
ZA965234B (en) 1997-03-06
KR970010776A (ko) 1997-03-27
FI962937A7 (fi) 1997-02-04
ITMI951716A1 (it) 1997-02-03
TW413635B (en) 2000-12-01
TR199600691A2 (xx) 1998-03-21
ITMI951716A0 (it) 1995-08-03
DE69609576D1 (de) 2000-09-07
CN1055693C (zh) 2000-08-23
RU2155767C2 (ru) 2000-09-10
AU700214B2 (en) 1998-12-24
BR9603270A (pt) 1998-04-28
GR3034663T3 (en) 2001-01-31
UA46727C2 (uk) 2002-06-17
SI0757991T1 (en) 2000-12-31
CN1147516A (zh) 1997-04-16
FI962937A0 (fi) 1996-07-23

Similar Documents

Publication Publication Date Title
MX9603110A (es) Forma cristalina biodisponible de cefuroxima axetil.
MX9205169A (es) Proceso para la produccion de gel suave.
FI973365A7 (fi) Menetelmä PHA-polymeerien mikrobiologiseksi tuottamiseksi
EP0379145A3 (en) Substituted quinolinecarboxylic acids
ES2193241T3 (es) Nuevas n-2-oxo2.3.4.5-tetrajodrp-1h-1,5-benzodiazepin-3-il)-3-amidas.
PT1165051E (pt) Processo para a preparacao de uma forma de dosagem oral biodisponivel de cefuroxima axetil
ES2008418A6 (es) Un procedimiento para la obtencioon de nueva forma cristalina del clavulanato de potasio y de composiciones del mismo.
BR9001798A (pt) Processo para a preparacao de cloreto de 2,2,4-tricloro-4-cianobutanoila,de 3,3,5,6-tetracloro-3,4-dihidropiridina-2-ona e de 3,5,6-tricloropiridina-2-ol
CO4560583A1 (es) Composiciones de copolimeros de impacto de polipropileno modificado y el proceso para obtener tales composiciones
FR2686898B1 (fr) Methode de production de la l-phenylalanine.
IT1277583B1 (it) Forma cristallina del tetrakis-(2,4-di-t-butilfenil)-4,4'- bifenilene difosfonito
EP0736508A4 (en) METHOD FOR PURIFYING 1,1,1,3,3-PENTAFLUORO-2,3-DICHLOROPROPANE
ID26405A (id) Pemurnian karboksaldehida
NO962620D0 (no) Nye mellomprodukter for syntese av L-aspartyl-D--aminoalkanoyl-(S)-N--alkylbenzylamider anvendbare son kunstige sötningsmidler
EP0032113A3 (en) Antiinflammatory 4,5-diaryl-alpha-(polyhaloalkyl)-1h-imidazole-2-methanols
ITRM960874A0 (it) Procedimento migliorato per la produzione di 5-idrossimetiltiazolo
ES2165376T3 (es) Procedimiento de moldeado de polipropileno sindiotactico.
FR2665696B1 (fr) Procede de purification du sel gemme obtenu par voie electrostatique.
TH28669B (th) รูปผลึกที่ใช้ได้ในทางชีววิทยาของเซฟฟูรอกซีมแอกซีติล
GR3026354T3 (en) Piperazinylpyridinyl water clathrates
ITVI930098A0 (it) Ciclo di lavorazione per la produzione di pelli tipo nabuk
FR2357251A1 (fr) 1-methyl-4-(2-carboxy-1-thioxanthan-9-ylidene)-piperidine
ITVI920198A1 (it) Ciclo di lavorazione per la produzione di pelli tipo nabuk
ITMI930705A0 (it) Processo per la produzione di alimenti per animali di migliorata assimilabilita'
RO87215A2 (ro) Procedeu de obtinere a mai multor straturi de piei din piei de categorii mari